Skip to main content
. 2016 Dec 14;2016:8201642. doi: 10.1155/2016/8201642

Figure 2.

Figure 2

High level of HERV-K (HML-2) predicts poor survival in HCC. Patients with higher HERV-K (HML-2) expression (n = 42) showed reduced survival time compared with patients with lower levels of HERV-K (HML-2) expression (n = 42) by the Kaplan-Meier survival curve analyses (log-rank test: P < 0.01).